LaxminarayanS, ReifmanJ, EdwardsSS, et al.: Bolus estimation—rethinking the effect of meal fat content. Diabetes Technol Ther, 2015; 17:860–866.
2.
BasuR, DiCamilloB, ToffoloG, et al.: Use of a novel triple-tracer approach to assess postprandial glucose metabolism. Am J Physiol Endocrinol Metab, 2003; 284:55–69.
3.
CobelliC, Dalla ManC, ToffoloG, et al.: The oral minimal model method. Diabetes, 2014; 63:1203–1213.
4.
Dalla ManC, CampioniM, PolonskyKS, et al.: Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals. Diabetes, 2005; 54:3265–3273.
5.
Dalla ManC, CaumoA, BasuR, et al.: Measurement of selective effect of insulin on glucose disposal from labeled glucose oral test minimal model. Am J Physiol Endocrinol Metab, 2005; 289:E909–E914.
6.
BasuR, Dalla ManC, CampioniM, et al.: Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction. Diabetes, 2006; 55:2001–2014.
7.
ToffoloG, BasuR, Dalla ManC, et al.: Assessment of postprandial glucose metabolism: conventional dual- vs. triple-tracer method. Am J Physiol Endocrinol Metab, 2006; 291:E800–E806.
8.
AbumradNN, CherringtonAD, WilliamsPE, et al.: Absorption and disposition of a glucose load in the conscious dog. Am J Physiol, 1982; 242:E398–E406.
9.
CherringtonAD. Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabete, 1999; 48:1198–1214.
10.
Dalla ManC, CaumoA, BasuR, et al.: Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method. Am J Physiol Endocrinol Metab, 2004; 287:E637–E643.
11.
HinshawL, SchiavonM, MalladA, et al.: Effects of delayed gastric emptying on postprandial glucose kinetics, insulin sensitivity, and beta-cell function. Am J Physiol Endocrinol Metab, 2014; 307:E494–E502.
12.
CherringtonAD, EdgertonD, SindelarDK: The direct and indirect effects of insulin on hepatic glucose production in vivo. Diabetologia, 1998; 41:987–996.
13.
CherringtonAD, VranicM: Role of glucagon and insulin in control of glucose turnover. Metabolism, 1971; 20:625–628.
14.
HolsteLC, ConnollyCC, MooreMC, et al.: Physiological changes in circulating glucagon alter hepatic glucose disposition during portal glucose delivery. Am J Physiol, 1997; 273:E488–E496.
15.
RamnananCJ, EdgertonDS, KraftG, et al.: Physiologic action of glucagon on liver glucose metabolism. Diabetes Obes Metab, 2011; 13(Suppl 1):118–125.
16.
BasuA, BasuR, ShahP, et al.: Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes, 2000; 49:272–283.
17.
BasuA, BasuR, ShahP, et al.: Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity. Diabetes, 2001; 50:1351–1362.
18.
ElleriD, AllenJM, HarrisJ, et al.: Absorption patterns of meals containing complex carbohydrates in type 1 diabetes. Diabetologia, 2013; 56:1108–1117.
19.
BoulbyP, MooreR, GowlandP, et al.: Fat delays emptying but increases forward and backward antral flow as assessed by flow-sensitive magnetic resonance imaging. Neurogastroenterol Motil, 1999; 11:27–36.
20.
RodenM, PerseghinG, PetersenKF, et al.: The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans. J Clin Invest, 1996; 97:642–648.
21.
PetersenKF, LaurentD, RothmanDL, et al.: Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. J Clin Invest, 1998; 101:1203–1209.
22.
MagnussonI, RothmanDL, JuckerB, et al.: Liver glycogen turnover in fed and fasted humans. Am J Physiol, 1994; 266:E796–E803.
23.
MagnussonI, RothmanDL, GerardDP, et al.: Contribution of hepatic glycogenolysis to glucose production in humans in response to a physiological increase in plasma glucagon concentration. Diabetes, 1995; 44:185–189.
24.
HinshawL, Dalla ManC, NandyDK, et al.: Diurnal pattern of insulin action in type 1 diabetes: implications for a closed-loop system. Diabetes, 2013; 62:2223–2229.
25.
MalladA, HinshawL, SchiavonM, et al.: Exercise effects on postprandial glucose metabolism in type 1 diabetes: a triple-tracer approach. Am J Physiol Endocrinol Metab, 2015; 308:E1106–E1115.
26.
GerichJE, LangloisM, NoaccoC, et al.: Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. J Clin Invest, 1976; 58:320–325.
27.
SindelarDK, ChuCA, RohlieM, et al.: The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes, 1997; 46:187–196.
28.
RodenM, PriceTB, PerseghinG, et al.: Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest, 1996; 97:2859–2865.
29.
FerranniniE, BarrettEJ, BevilacquaS, et al.: Effect of fatty acids on glucose production and utilization in man. J Clin Invest, 1983; 72:1737–1747.
30.
VelhoG, PetersenKF, PerseghinG, et al.: Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J Clin Invest, 1996; 98:1755–1761.
31.
HwangJ-H, PerseghinG, RothmanDL, et al.: Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion. J Clin Invest, 1995; 95:783–787.
32.
ShahP, VellaA, BasuA, et al.: Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans. Diabetes, 2002; 51:301–310.
33.
RandlePJ, HalesCN, GarlandPB, et al.: The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet, 1963; 1:7285–7289.
34.
RodenM, KrssakM, StinglH, et al.: Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes, 1999; 48:358–364.
35.
BellKJ, SmartCE, SteilGM, et al.: Impact of fat, protein, and glycemic index on postprandial glucose control in type 1 diabetes: implications for intensive diabetes management in the continuous glucose monitoring era. Diabetes Care, 2015; 38:1008–1015.
36.
ThabitH, Lubina-SolomonA, StadlerM, et al.: Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study. Lancet Diabetes Endocrinol, 2014; 2:701–709.
37.
KovatchevBP, RenardE, CobelliC, et al.: Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas. Diabetes Care, 2014; 37:1789–1796.
